207 related articles for article (PubMed ID: 1889842)
1. Prolonged angiotensin II antagonism in spontaneously hypertensive rats. Hemodynamic and biochemical consequences.
Bunkenburg B; Schnell C; Baum HP; Cumin F; Wood JM
Hypertension; 1991 Sep; 18(3):278-88. PubMed ID: 1889842
[TBL] [Abstract][Full Text] [Related]
2. Antihypertensive and hormonal activity of MK 954 in spontaneously hypertensive rats.
Mizuno K; Niimura S; Tani M; Haga H; Gomibuchi T; Sanada H; Fukuchi S
Eur J Pharmacol; 1992 May; 215(2-3):305-8. PubMed ID: 1396995
[TBL] [Abstract][Full Text] [Related]
3. Acute myocardial and vascular responses to specific angiotensin II antagonism in the spontaneously hypertensive rat.
Cody RJ; Binkley PF; Haas GJ; Brown DM
Am J Hypertens; 1995 May; 8(5 Pt 1):500-8. PubMed ID: 7662227
[TBL] [Abstract][Full Text] [Related]
4. Central DuP 753 does not lower blood pressure in spontaneously hypertensive rats.
DePasquale MJ; Fossa AA; Holt WF; Mangiapane ML
Hypertension; 1992 Jun; 19(6 Pt 2):668-71. PubMed ID: 1592465
[TBL] [Abstract][Full Text] [Related]
5. The antihypertensive effect of the angiotensin II receptor antagonist DuP 753 may not be due solely to angiotensin II receptor antagonism.
Ohlstein EH; Gellai M; Brooks DP; Vickery L; Jugus J; Sulpizio A; Ruffolo RR; Weinstock J; Edwards RM
J Pharmacol Exp Ther; 1992 Aug; 262(2):595-601. PubMed ID: 1501114
[TBL] [Abstract][Full Text] [Related]
6. Hypotensive action of DuP 753, an angiotensin II antagonist, in spontaneously hypertensive rats. Nonpeptide angiotensin II receptor antagonists: X.
Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
Hypertension; 1990 May; 15(5):459-68. PubMed ID: 2185150
[TBL] [Abstract][Full Text] [Related]
7. Effects of angiotensin subtype 1 and subtype 2 receptor antagonists in normotensive versus hypertensive rats.
Tofovic SP; Pong AS; Jackson EK
Hypertension; 1991 Dec; 18(6):774-82. PubMed ID: 1743758
[TBL] [Abstract][Full Text] [Related]
8. Depressor effect of blocking angiotensin subtype 1 receptors in anterior hypothalamus.
Yang RH; Jin H; Wyss JM; Oparil S
Hypertension; 1992 May; 19(5):475-81. PubMed ID: 1568766
[TBL] [Abstract][Full Text] [Related]
9. Effects of chronic treatment with losartan and enalaprilat on [3H]-norepinephrine release from isolated atria of Wistar-Kyoto and spontaneously hypertensive rats.
Foucart S; Patrick SK; Oster L; de Champlain J
Am J Hypertens; 1996 Jan; 9(1):61-9. PubMed ID: 8834708
[TBL] [Abstract][Full Text] [Related]
10. Lack of a centrally-mediated antihypertensive effect following acute or chronic central treatment with AT1-receptor antagonists in spontaneously hypertensive rats.
Bunting MW; Widdop RE
Br J Pharmacol; 1995 Dec; 116(8):3181-90. PubMed ID: 8719794
[TBL] [Abstract][Full Text] [Related]
11. Effect of AT1 angiotensin-receptor blockade on structure and function of small arteries in SHR.
Li JS; Sharifi AM; Schiffrin EL
J Cardiovasc Pharmacol; 1997 Jul; 30(1):75-83. PubMed ID: 9268224
[TBL] [Abstract][Full Text] [Related]
12. Blocking hypothalamic AT1 receptors lowers blood pressure in salt-sensitive rats.
Yang RH; Jin H; Chen SJ; Wyss JM; Oparil S
Hypertension; 1992 Dec; 20(6):755-62. PubMed ID: 1452291
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of SR 47436 (BMS-186295), a non-peptide angiotensin AT1 receptor antagonist in hypertensive rat models.
Lacour C; Canals F; Galindo G; Cazaubon C; Segondy D; Nisato D
Eur J Pharmacol; 1994 Nov; 264(3):307-16. PubMed ID: 7698170
[TBL] [Abstract][Full Text] [Related]
14. Chronic angiotensin II type 1 receptor antagonism in genetic hypertension: effects on vascular structure and reactivity.
Oddie CJ; Dilley RJ; Kanellakis P; Bobik A
J Hypertens; 1993 Jul; 11(7):717-24. PubMed ID: 8228190
[TBL] [Abstract][Full Text] [Related]
15. Effects of renin-angiotensin blockade on sympathetic reactivity and beta-adrenergic pathway in the spontaneously hypertensive rat.
K-Laflamme A; Oster L; Cardinal R; de Champlain J
Hypertension; 1997 Aug; 30(2 Pt 1):278-87. PubMed ID: 9260993
[TBL] [Abstract][Full Text] [Related]
16. Control of blood pressure and end-organ damage in maturing salt-loaded stroke-prone spontaneously hypertensive rats by oral angiotensin II receptor blockade.
Camargo MJ; von Lutterotti N; Campbell WG; Pecker MS; James GD; Timmermans PB; Laragh JH
J Hypertens; 1993 Jan; 11(1):31-40. PubMed ID: 8382237
[TBL] [Abstract][Full Text] [Related]
17. Effects of the angiotensin II receptor antagonist losartan on 24-hour blood pressure profiles of primary and secondary hypertensive rats.
Schnecko A; Witte K; Lemmer B
J Cardiovasc Pharmacol; 1995 Aug; 26(2):214-21. PubMed ID: 7475045
[TBL] [Abstract][Full Text] [Related]
18. Cardiac and vascular effects of long-term losartan treatment in stroke-prone spontaneously hypertensive rats.
Gohlke P; Linz W; Schölkens BA; Wiemer G; Unger T
Hypertension; 1996 Sep; 28(3):397-402. PubMed ID: 8794823
[TBL] [Abstract][Full Text] [Related]
19. Effects of prolonged blockade of the renin angiotensin system on striated muscle microcirculation of spontaneously hypertensive rats.
Scheidegger KJ; Wood JM; van Essen H; Struijker-Boudier HA
J Pharmacol Exp Ther; 1996 Sep; 278(3):1276-81. PubMed ID: 8819512
[TBL] [Abstract][Full Text] [Related]
20. Effects of losartan, a nonpeptide angiotensin II receptor antagonist, on cardiac hypertrophy and the tissue angiotensin II content in spontaneously hypertensive rats.
Mizuno K; Tani M; Hashimoto S; Niimura S; Sanada H; Watanabe H; Ohtsuki M; Fukuchi S
Life Sci; 1992; 51(5):367-74. PubMed ID: 1385640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
